Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
VELA OPERATIONS SINGAPORE PTE
{{company.company_channel.channel_name}}
Media Room
Latest
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan
2023-10-02 22:16
Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya
2022-08-03 14:00
Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus
2022-07-26 22:09
Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus
2022-07-26 21:00
Vela Diagnostics Launches Multiplex PCR-Based Test for Detecting UTI Pathogens and Antimicrobial Resistance Genes
2022-05-17 22:00
Media Pooling Strategy to Increase Testing Throughput Added to Vela Diagnostics' ViroKey SARS-CoV-2 RT-PCR Test v2.0
2022-04-22 20:00
Vela Diagnostics Launches Focused (60 Genes) and Comprehensive (525 Genes) NGS-Based Pan-Cancer Panels
2022-03-28 15:00
Healthcare providers can expect to receive US$725 reimbursement from CMS when using NGS-based Sentosa(R) SQ HIV-1 Genotyping Assay
2022-01-07 22:00
Vela Diagnostics expands automation options for SARS-CoV-2 RT-PCR Test
2021-11-20 01:15
Vela Diagnostics Announces Collaboration with the National Cancer Centre of Singapore to Refine Novel Cancer Therapy
2021-06-04 08:00
Vela Diagnostics adds two SARS-CoV-2 assays for virus genotyping, and variant identification to its COVID-19 testing solutions
2021-02-26 16:00
Vela Diagnostics' SARS-CoV-2 RT-PCR Test v2.0 Authorized for Emergency Use in the U.S.
2020-09-23 12:53
FDA issues Emergency Use Authorization to Vela Diagnostics' coronavirus PCR test
2020-08-06 11:42
Vela Diagnostics receives CE-IVD approval and Provisional Authorisation from the Health Sciences Authority in Singapore for automated COVID-19 detection test
2020-07-13 17:37
Vela Diagnostics receives CE mark for COVID-19 detection test
2020-04-24 19:12
Vela Diagnostics receives BARDA funding to develop COVID-19 tests
2020-04-20 21:00
Vela Diagnostics' COVID-19 test receives provisional authorisation from the Health Sciences Authority in Singapore
2020-04-16 12:41
Vela Diagnostics to offer manual ViroKey™ SARS-CoV-2 RT-PCR Test after completion of Emergency Use Authorization validation, targeted to be complete by early April 2020
2020-03-30 12:06
Vela Genomics Launches NGS Clinical Interpretation and Reporting
2017-03-07 10:21
Vela Diagnostics, a Turnkey Manufacturer for IVD NGS and PCR Workflow Solutions Announces its 2016 Results and Highlights
2017-02-01 13:00
1
2